Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 7,700.00
-20.00 (-0.26%)
At close: Nov 26, 2025
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 118.2 billion as of November 26, 2025. Its market cap has decreased by -10.78% in one year.
Market Cap
118.20B
Enterprise Value
358.03B
Revenue
707.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,700.00
Market Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 118.20B, an increase of 349.51%. That is a compound annual growth rate of 5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 118.20B | -1.53% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | 325.44B | 24.71% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.84T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.54T |
| Yuhan | 8.55T |
| Peptron | 7.30T |
| LigaChem Biosciences | 6.25T |